Connect your AI

Trimas TRS Finance Lease, Right-of-Use Asset, after Accumulated Amortization

Finance Lease, Right-of-Use Asset, after Accumulated Amortization at other companies

GreifGEF

——

Sonoco ProductsSON

——

West Pharmaceutical ServicesWST

——

Chart IndustriesGTLS

——

Other financials

Income statement

Revenue$168.3M+10.4%

Gross profit$36.9M+12.3%

Operating income$6.9M-3.6%

Net income$800.8M+6,348%

EPS (diluted)$21.40+7,033%

Balance sheet

Cash & equivalents$1.3B+3,904%

Total debt$439.9M-9.2%

Total equity$1.4B+111%

Total assets$2.3B+64.8%

Cash flow

Operating cash flow-$19.4M-311%

CapEx$5.2M-59.7%

Free cash flow-$24.6M-556%

Valuation

Market cap$1.56B+41.9%

Enterprise value$692.33M-65.6%

P/E1.7×-33.2×

P/S2.4×+0.6×

Profitability

Gross margin-0.1%-2.1pp

Operating margin8%-1.0pp

Net margin137.3%+132pp

FCF margin7.3%+3.1pp

Returns & leverage

Return on equity85.1%+80.4pp

Debt / equity0.3×-0.4×

Current ratio4.9×+2.0×

Where this comes from

Reported directly by Trimas in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeaseRightOfUseAsset.

The official record: Trimas’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Trimas's finance lease, right-of-use asset, after accumulated amortization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Trimas's finance lease, right-of-use asset, after accumulated amortization?: Trimas (TRS) reported finance lease, right-of-use asset, after accumulated amortization of $2.05M in Q1 2026.
How has Trimas's finance lease, right-of-use asset, after accumulated amortization changed year-over-year?: Trimas's finance lease, right-of-use asset, after accumulated amortization decreased by 4.7% year-over-year, from $2.15M to $2.05M.